SDC1 and Miyoshi myopathy: In addition, Fichou and colleagues investigated the therapeutic efficacy of 9E7.4, an anti-mouse CD138 derivative radiolabeled with either bismuth-213 or lutetium-177, in an MM mouse model, showing little benefit for mouse survival (167).